期刊文献+

青藤碱对类风湿关节炎患者成纤维样滑膜细胞增殖及基质金属蛋白酶-3表达的影响 被引量:22

Effects of Sinomenine on Proliferation of Human Fibroblast-like Synoviocyte and Expression of MMP-3 mRNA from Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的观察青藤碱对体外培养类风湿关节炎患者成纤维样滑膜细胞增殖以及基质金属蛋白酶-3(MMP-3)mRNA含量的影响。方法培养人成纤维样滑膜细胞,分为青藤碱高、中、低剂量组和空白对照组,经青藤碱干预后,用四甲基偶氮唑蓝法测定细胞增殖情况,用半定量RT-PCR方法检测成纤维细胞中MMP-3mRNA的表达。结果经青藤碱干预后的人成纤维样滑膜细胞的增殖率受到显著抑制(P<0.05),其中高剂量组的改变差异尤为显著(P<0.01)。MMP-3的mRNA表达水平较之空白对照组有显著下降(P<0.05),且高剂量组的差异尤为显著(P<0.01)。结论青藤碱可以抑制类风湿关节炎患者成纤维样滑膜细胞的增殖并下调MMP-3的表达,推断这可能是青藤碱治疗类风湿关节炎的一种机理。 Objective To observe the effect of sinomenine on the proliferation of fibroblast-like synoviocytes obtained by digesting synovial tissues with collagens and were divided into four groups: sinomenine high, middle, low concentration and control group. The proliferation of FLS was assessed by methyl-thiazolyl-tetrazolium (MTT) assay and the mRNA expression of MMP-3 was measured by semi-quantitative RT-PCR respectively after treated by sinomenine. Results The rate of FLS proliferation was significantly reduced in groups treated by sinomenine. Compared with control group, the mRNA expression of MMP-3 markly decreased in sinomenine groups (P〈0.05) and especially in sinomenine high group (P〈0.01). Conclusion Sinomenine can effectively inhibit the proliferation of FLS and reduce the mRNA expression of MMP-3 of FLS in rheumatoid arthritis, that may be a mechanism in therapy of rheumatoid arthritis by sinomenine.
出处 《中国中医药信息杂志》 CAS CSCD 2008年第3期23-25,共3页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 类风湿关节炎 青藤碱 成纤维样滑膜细胞 基质金属蛋白酶-3 rheumatoid arthritis sinomenine fibroblast-like synoviocytes MMP-3
  • 相关文献

参考文献11

  • 1Takayanagi H, Iizuka H, Juli T, et al. Involvement of receptor activator of nuclear factor KappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis[J]. Arthritis Rheum, 2000,43(2): 259-269.
  • 2汪倪萍,魏伟.中药活性成分的抗炎免疫和镇痛作用[J].中国药理学通报,2003,19(4):366-369. 被引量:48
  • 3Arnet FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988,31: 315-324.
  • 4王勇,方勇飞,周新,钟兵.不同浓度青藤碱对大鼠滑膜细胞因子mRNA表达的影响[J].中国中医药信息杂志,2003,10(12):25-27. 被引量:9
  • 5Okada Y, Nagase H, Harris ED. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components[J]. J Biol Chem, 1986,261: 14245-14255.
  • 6Han ZN, Boyle LD, Chang LF, et al. c-jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis[J]. J Clin Invest, 2001,108(1): 73-81.
  • 7Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase l[J]. Arch Biochern Biophys, 1988, 67(1): 211-216.
  • 8王晓霞,李小峰,王来远,胡学芳,张琳,李雪飞.类风湿关节炎血清基质金属蛋白酶-3水平及其影响因素的探讨[J].中华风湿病学杂志,2004,8(1):16-19. 被引量:31
  • 9Yamanaka H, Matsuda Y, Tanaka M, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement in patients with early rheumatoid arthritis[J]. Arthritis Rheum, 2000,43(4): 852.
  • 10Walakovits LA, Moore VL, Bhardwaj N, et al. Detection of stromelysin and collagnase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury[J]. Arthritis Rheum, 1992,35(1): 35-42.

二级参考文献25

  • 1王斌,陈敏珠,徐叔云.大鼠滑膜细胞的分离和培养[J].中国药理学通报,1994,10(1):73-74. 被引量:48
  • 2杨沁 陈敏珠.黄芪总苷的抗炎与镇痛作用机制[J].安徽医科大学学报,2000,35(5):376-376.
  • 3Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 4Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 5Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 6Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 7Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 8Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 9Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 10Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.

共引文献85

同被引文献336

引证文献22

二级引证文献212

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部